Question 1

How does kava work to reduce anxiety?

Accepted Answer

Kava's active compounds, called kavalactones, work primarily by binding to GABA-A receptors in the brain, enhancing the calming effects of gamma-aminobutyric acid (GABA), the body's primary inhibitory neurotransmitter. Kavalactones also modulate voltage-gated ion channels and affect dopamine and serotonin pathways. This multi-target mechanism produces anxiolytic and muscle-relaxant effects without significantly impairing cognitive function at standard doses. Kava's effects are often described as similar to benzodiazepines but without the same addiction risk. Evidence Level: C.

Question 2

What medications interact with kava?

Accepted Answer

Kava has significant drug interactions and should not be combined with central nervous system depressants like benzodiazepines, alcohol, barbiturates, or anticonvulsants, as this can cause excessive sedation and respiratory depression. Kava inhibits several CYP450 liver enzymes, potentially increasing blood levels of medications metabolized through these pathways. Avoid combining kava with hepatotoxic medications, acetaminophen, statins, or other herbs affecting liver function. Due to cumulative liver strain, kava should never be combined with alcohol. Evidence Level: C.

Question 3

What is the recommended dosage of kava for anxiety?

Accepted Answer

The standard adult dosage for anxiety is 120-250 mg of kavalactones daily, typically divided into two or three doses. This usually corresponds to 1-2 grams of dried kava root or 2-4 mL of liquid extract daily. Standardized extracts containing 70% kavalactones are commonly used in clinical studies. Effects typically begin within 1-2 hours of consumption. Long-term daily use beyond 3 months is not recommended without medical supervision due to potential liver concerns. Evidence Level: C.

Question 4

Is kava safe during pregnancy and breastfeeding?

Accepted Answer

Kava is considered unsafe during pregnancy and breastfeeding and should be avoided entirely. There is insufficient safety data for fetal development, and kavalactones may cross the placenta or pass into breast milk. Kava's effects on the liver and central nervous system pose potential risks to developing fetuses and nursing infants. Additionally, kava's sedative properties could affect infant development and feeding patterns. Women who are pregnant, planning pregnancy, or breastfeeding should not use kava. Evidence Level: D.

Question 5

Does kava cause liver damage?

Accepted Answer

Reports of kava-related liver damage led to bans in several countries during the early 2000s. However, subsequent analysis suggests most cases involved poor-quality products, incorrect plant parts (leaves and stems instead of noble root), or pre-existing liver conditions. Quality-controlled kava root extracts from reputable sources appear to have a low risk of hepatotoxicity when used appropriately at recommended doses. Individuals with liver disease, heavy alcohol use, or those taking hepatotoxic medications should avoid kava entirely. Evidence Level: C.

Drug	Severity	Description
Alprazolam (Xanax)	Severe	Kava combined with benzodiazepines may cause excessive sedation, coma, or respiratory depression. A case of coma has been reported with this combination.
Acetaminophen (Tylenol)	Severe	Kava combined with acetaminophen may increase risk of liver damage, as both are hepatotoxic.
Alcohol	Severe	Combining kava with alcohol significantly increases the risk of liver damage and excessive CNS depression.
Levodopa	Severe	Kava may reduce the effectiveness of levodopa, worsening Parkinsonian symptoms. Case reports document worsening of symptoms.

Kava

Sources & Citations

Valerian

Passionflower

St. John's Wort

⚠️ Not Recommended During Pregnancy or Nursing

4 Known Drug Interactions — Some May Be Serious

Contraindications

Possible Side Effects

What is a herb–drug interaction?

Known Drug Interactions (4)

Summary

Background

Traditional uses

Active compounds

Mechanism of action

Clinical evidence

Safety & adverse effects

Drug interactions

Evidence summary

PubMed sources

Government sources